Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.606 SEK | -5.31% | -8.46% | -50.73% |
Apr. 16 | Nanexa AB Announces Approval of Clinical Trial Application for NEX-22 Study Delayed | CI |
Mar. 08 | Transcript : Nanexa AB - Special Call |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Equities
- NANEXA Stock
- Revisions Nanexa AB